Supplementary Data 2 from High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab
收藏Figshare2021-09-01 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Supplementary_Data_2_from_High_Response_Rate_and_Durability_Driven_by_HLA_Genetic_Diversity_in_Patients_with_Kidney_Cancer_Treated_with_Lenvatinib_and_Pembrolizumab/22526897
下载链接
链接失效反馈官方服务：
资源简介：
HLA class-I allele data along with mean HED values for the lenvatinib/pembrolizumab and MSK-IMPACT cohorts.
创建时间：
2021-09-01
